229 related articles for article (PubMed ID: 24475156)
1. Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
Souza Lda C; Camargo R; Demasi M; Santana JM; de Sá CM; de Freitas SM
PLoS One; 2014; 9(1):e86600. PubMed ID: 24475156
[TBL] [Abstract][Full Text] [Related]
2. A Bowman-Birk inhibitor induces apoptosis in human breast adenocarcinoma through mitochondrial impairment and oxidative damage following proteasome 20S inhibition.
Mehdad A; Brumana G; Souza AA; Barbosa J; Ventura MM; de Freitas SM
Cell Death Discov; 2016; 2():15067. PubMed ID: 27551492
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds.
Joanitti GA; Azevedo RB; Freitas SM
Cancer Lett; 2010 Jul; 293(1):73-81. PubMed ID: 20133052
[TBL] [Abstract][Full Text] [Related]
4. Effects of black-eyed pea trypsin/chymotrypsin inhibitor on proteolytic activity and on development of Anthonomus grandis.
Franco OL; dos Santos RC; Batista JA; Mendes AC; de Araújo MA; Monnerat RG; Grossi-de-Sá MF; de Freitas SM
Phytochemistry; 2003 Jun; 63(3):343-9. PubMed ID: 12737983
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the black-eyed pea trypsin and chymotrypsin inhibitor-alpha-chymotrypsin complex.
de Freitas SM; de Mello LV; da Silva MC; Vriend G; Neshich G; Ventura MM
FEBS Lett; 1997 Jun; 409(2):121-7. PubMed ID: 9202130
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the Bowman-Birk Inhibitor from Vigna unguiculata seeds in complex with beta-trypsin at 1.55 A resolution and its structural properties in association with proteinases.
Barbosa JA; Silva LP; Teles RC; Esteves GF; Azevedo RB; Ventura MM; de Freitas SM
Biophys J; 2007 Mar; 92(5):1638-50. PubMed ID: 17142290
[TBL] [Abstract][Full Text] [Related]
7. Bowman-Birk protease inhibitor from Vigna unguiculata seeds enhances the action of bradykinin-related peptides.
da Cunha Morales Álvares A; Schwartz EF; Amaral NO; Trindade NR; Pedrino GR; Silva LP; de Freitas SM
Molecules; 2014 Oct; 19(11):17536-58. PubMed ID: 25361421
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic structure of a complex between trypsin and a nonapeptide derived from a Bowman-Birk inhibitor found in Vigna unguiculata seeds.
Fernandes JPC; Mehdad A; Valadares NF; Mourão CBF; Ventura MM; Barbosa JARG; Freitas SM
Arch Biochem Biophys; 2019 Apr; 665():79-86. PubMed ID: 30817908
[TBL] [Abstract][Full Text] [Related]
9. A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea.
Zhang L; Chen X; Wu Y; Zhou M; Ma C; Xi X; Chen T; Walker B; Shaw C; Wang L
Sci Rep; 2018 Apr; 8(1):5851. PubMed ID: 29643444
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human and yeast 20S proteasome by analogues of trypsin inhibitor SFTI-1.
Dębowski D; Pikuła M; Lubos M; Langa P; Trzonkowski P; Lesner A; Łęgowska A; Rolka K
PLoS One; 2014; 9(2):e89465. PubMed ID: 24586798
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization affects the kinetics and thermodynamics of the interaction of a Bowman-Birk inhibitor with proteases.
Brand GD; Pires DA; Furtado JR; Cooper A; Freitas SM; Bloch C
Arch Biochem Biophys; 2017 Mar; 618():9-14. PubMed ID: 28132757
[TBL] [Abstract][Full Text] [Related]
12. Identification and Target-Modification of SL-BBI: A Novel Bowman-Birk Type Trypsin Inhibitor from
Chen X; Chen D; Huang L; Chen X; Zhou M; Xi X; Ma C; Chen T; Wang L
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872343
[TBL] [Abstract][Full Text] [Related]
13. Primary structures of proteinase inhibitors from Phaseolus vulgaris var. nanus (cv. Borlotto).
Funk A; Weder JK; Belitz HD
Z Lebensm Unters Forsch; 1993 Apr; 196(4):343-50. PubMed ID: 8493818
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamics of the binding of chymotrypsin with the black-eyed pea trypsin and chymotrypsin inhibitor (BTCI).
de Freitas SM; Ikemoto H; Ventura MM
J Protein Chem; 1999 Apr; 18(3):307-13. PubMed ID: 10395449
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides.
Lum RT; Nelson MG; Joly A; Horsma AG; Lee G; Meyer SM; Wick MM; Schow SR
Bioorg Med Chem Lett; 1998 Feb; 8(3):209-14. PubMed ID: 9871656
[TBL] [Abstract][Full Text] [Related]
16. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
Chen YW; Huang SC; Lin-Shiau SY; Lin JK
Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
[TBL] [Abstract][Full Text] [Related]
17. Purification and primary structure determination of a Bowman-Birk trypsin inhibitor from Torresea cearensis seeds.
Tanaka AS; Sampaio MU; Marangoni S; de Oliveira B; Novello JC; Oliva ML; Fink E; Sampaio CA
Biol Chem; 1997; 378(3-4):273-81. PubMed ID: 9165081
[TBL] [Abstract][Full Text] [Related]
18. An infrared spectroscopic study on the secondary structure of the black-eyed pea trypsin and chymotrypsin inhibitor--amide I-III and V bands.
Bastos Aragão J; Mateus Ventura M
An Acad Bras Cienc; 1986 Sep; 58(3):339-43. PubMed ID: 3499104
[TBL] [Abstract][Full Text] [Related]
19. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
[TBL] [Abstract][Full Text] [Related]
20. A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans.
Ye XY; Ng TB; Rao PF
Biochem Biophys Res Commun; 2001 Nov; 289(1):91-6. PubMed ID: 11708782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
